ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

CPHI China Pharma Holdings Inc

0.3148
0.01135 (3.74%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
China Pharma Holdings Inc AMEX:CPHI AMEX Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.01135 3.74% 0.3148 0.324 0.30 0.30 183,851 01:00:00

CPHI to Hold Second Quarter 2016 Earnings Conference Call on Friday August 12, 2016 at 8:30 a.m. ET

01/08/2016 11:00am

PR Newswire (US)


China Pharma (AMEX:CPHI)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more China Pharma Charts.

HAIKOU, China, Aug. 1, 2016 /PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE MKT: CPHI), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that it plans to hold its second quarter 2016 earnings conference call on Friday, August 12, 2016 at 8:30 a.m. ET.

Listeners may access the call by dialing 1-866-519-4004 or 65-671-350-90 for international callers, Conference ID # 54240245. A replay of the call will be accessible through August 20, 2016 by dialing 1-855-452-5696 or 61-281-990-299 for international callers, Conference ID # 54240245.

About China Pharma Holdings, Inc.

China Pharma Holdings, Inc. is a specialty pharmaceutical company that develops, manufactures and markets a diversified portfolio of products focused on conditions with a high incidence and high mortality rates in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company's cost-effective, high-margin business model is driven by market demand and supported by new GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding nationwide distribution network across all major cities and provinces in China. The Company's wholly-owned subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd., is located in Haikou City, Hainan Province. For more information about China Pharma Holdings, Inc., please visit http://www.chinapharmaholdings.com. The Company routinely posts important information on its website.

Contact:

Ms. Diana Na Huang, CFA,
hps@chinapharmaholdings.com
Tel: 86-898-66811730

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cphi-to-hold-second-quarter-2016-earnings-conference-call-on-friday-august-12-2016-at-830-am-et-300306755.html

SOURCE China Pharma Holdings, Inc.

Copyright 2016 PR Newswire

1 Year China Pharma Chart

1 Year China Pharma Chart

1 Month China Pharma Chart

1 Month China Pharma Chart

Your Recent History

Delayed Upgrade Clock